Story

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts shrinking after vaccination.

July 22, 2026 World Fox News

A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts shrinking after vaccination.

This story was indexed from the original publisher. Read at Fox News

Leave a Reply

Your email address will not be published. Required fields are marked *